Founder Phil Frengs with Nick Galante

Posted on: March 19, 2021

In Categories:

Funding the cure

Cutting-edge research aimed at delaying the progression of the disease or stopping its course.

Subscribe to our newsletter for exclusive content and all the behind-the-scenes details.